{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:25:45Z","timestamp":1787099145476,"version":"build-2736575974"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"vor","delay-in-days":70,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Malignant rhabdoid tumor (MRT) is a highly aggressive pediatric neoplasm defined by SMARCB1\/INI1 loss, and primary orbital involvement is rare.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>A 20-month-old girl presented with rapidly progressive left proptosis. Magnetic resonance imaging demonstrated a 2.1\u2009\u00d7\u20091.3\u2009\u00d7\u20091.6\u00a0cm temporal retrobulbar mass with focal bone erosion. The primary tumor was treated with piecemeal excision, followed by adjuvant chemoradiotherapy. Pathology showed large epithelioid tumor cells with rhabdoid morphology. Immunohistochemistry revealed diffuse expression of vimentin, CK, and CD34, but INI1 loss and SALL4 negativity. Fluorescence in situ hybridization confirmed a heterozygous SMARCB1 deletion. However, rapid local progression with extension into the temporal lobe occurred 3 months after completion of the treatment. Salvage therapy led to marked radiographic regression, but was discontinued due to severe cytopenias. The patient died of intracranial progression 34 months after the initial surgery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Orbital MRT can exhibit an atypical CD34-positive and SALL4-negative immunophenotype. The tumor demonstrates highly aggressive behavior, and adjuvant chemotherapy and radiotherapy may provide only temporary control.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s12672-026-05397-z","type":"journal-article","created":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T07:53:49Z","timestamp":1781078029000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Orbital malignant rhabdoid tumor with an aberrant immunophenotype: a case report"],"prefix":"10.1007","volume":"17","author":[{"given":"Hongqin","family":"Jia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongrong","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingwen","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,10]]},"reference":[{"issue":"7","key":"5397_CR1","doi-asserted-by":"publisher","first-page":"e551","DOI":"10.1634\/theoncologist.2018-0416","volume":"24","author":"H Cheng","year":"2019","unstructured":"Cheng H, Yang S, Cai S, et al. Clinical and prognostic characteristics of 53 cases of extracranial malignant rhabdoid tumor in children. A single-institute experience from 2007 to 2017. Oncologist. 2019;24(7):e551\u20138.","journal-title":"Oncologist"},{"issue":"1","key":"5397_CR2","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1002\/pbc.22285","volume":"54","author":"I Sultan","year":"2010","unstructured":"Sultan I, Qaddoumi I, Rodriguez-Galindo C, et al. Age, stage, and radiotherapy, but not primary tumor site, affects the outcome of patients with malignant rhabdoid tumors. Pediatr Blood Cancer. 2010;54(1):35\u201340.","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"5397_CR3","doi-asserted-by":"publisher","first-page":"103935","DOI":"10.1016\/j.jaapos.2024.103935","volume":"28","author":"FR Burgess","year":"2024","unstructured":"Burgess FR, Peden R, Thum C, et al. Malignant rhabdoid tumor of the orbit in an infant. J AAPOS. 2024;28(4):103935.","journal-title":"J AAPOS"},{"issue":"11","key":"5397_CR4","doi-asserted-by":"publisher","first-page":"3979","DOI":"10.1016\/j.radcr.2023.07.074","volume":"18","author":"S El Malih","year":"2023","unstructured":"El Malih S, Akammar A, El Mounssefe G, et al. Synchronous congenital malignant rhabdoid tumor of the orbit and cerebellar atypical teratoid\/rhabdoid tumor: Case report. Radiol Case Rep. 2023;18(11):3979\u201383.","journal-title":"Radiol Case Rep"},{"issue":"2","key":"5397_CR5","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1055\/a-0838-5604","volume":"237","author":"V Wilms","year":"2020","unstructured":"Wilms V, Jager M, Schlamann M, et al. Rhabdoid tumour of the orbit in a child. Klin Monbl Augenheilkd. 2020;237(2):205\u20136.","journal-title":"Klin Monbl Augenheilkd"},{"issue":"3","key":"5397_CR6","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1097\/MPH.0000000000001402","volume":"42","author":"A Biswas","year":"2020","unstructured":"Biswas A, Kumar R, Bakhshi S, et al. Multimodal management of congenital orbital malignant rhabdoid tumor: review of literature and report of a rare case. J Pediatr Hematol Oncol. 2020;42(3):228\u201333.","journal-title":"J Pediatr Hematol Oncol"},{"issue":"4","key":"5397_CR7","doi-asserted-by":"publisher","first-page":"292","DOI":"10.3109\/01676830.2014.900088","volume":"33","author":"K Mulay","year":"2014","unstructured":"Mulay K, Honavar SG. Primary, orbital, malignant extra-renal, non-cerebral rhabdoid tumour. Orbit. 2014;33(4):292\u20134.","journal-title":"Orbit"},{"issue":"1","key":"5397_CR8","first-page":"69","volume":"29","author":"S Karaman","year":"2013","unstructured":"Karaman S, Celkan T, Dervisoglu S, et al. Malignant rhabdoid tumor of the orbit. Turk Patoloji Derg. 2013;29(1):69\u201372.","journal-title":"Turk Patoloji Derg"},{"issue":"4","key":"5397_CR9","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1159\/000213643","volume":"223","author":"KH Kook","year":"2009","unstructured":"Kook KH, Park MS, Yim H, et al. A case of congenital orbital malignant rhabdoid tumor: systemic metastasis following exenteration. Ophthalmologica. 2009;223(4):274\u20138.","journal-title":"Ophthalmologica"},{"issue":"6","key":"5397_CR10","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1002\/pbc.20699","volume":"47","author":"H Watanabe","year":"2006","unstructured":"Watanabe H, Watanabe T, Kaneko M, et al. Treatment of unresectable malignant rhabdoid tumor of the orbit with tandem high-dose chemotherapy and gamma-knife radiosurgery. Pediatr Blood Cancer. 2006;47(6):846\u201350.","journal-title":"Pediatr Blood Cancer"},{"issue":"5","key":"5397_CR11","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/S1091-8531(99)70031-5","volume":"3","author":"DB Stidham","year":"1999","unstructured":"Stidham DB, Burgett RA, Davis MM, et al. Congenital malignant rhabdoid tumor of the orbit. J AAPOS. 1999;3(5):318\u201320.","journal-title":"J AAPOS"},{"issue":"2","key":"5397_CR12","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1001\/archopht.116.2.243","volume":"116","author":"K Gunduz","year":"1998","unstructured":"Gunduz K, Shields JA, Eagle RC Jr., et al. Malignant rhabdoid tumor of the orbit. Arch Ophthalmol. 1998;116(2):243\u20136.","journal-title":"Arch Ophthalmol"},{"issue":"9","key":"5397_CR13","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1001\/archopht.1991.01080090101031","volume":"109","author":"LN Johnson","year":"1991","unstructured":"Johnson LN, Sexton FM, Goldberg SH. Poorly differentiated primary orbital sarcoma (presumed malignant rhabdoid tumor). Radiologic and histopathologic correlation. Arch Ophthalmol. 1991;109(9):1275\u20138.","journal-title":"Arch Ophthalmol"},{"issue":"11","key":"5397_CR14","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1016\/S0161-6420(89)32666-2","volume":"96","author":"J Rootman","year":"1989","unstructured":"Rootman J, Damji KF, Dimmick JE. Malignant rhabdoid tumor of the orbit. Ophthalmology. 1989;96(11):1650\u20134.","journal-title":"Ophthalmology"},{"issue":"10","key":"5397_CR15","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1093\/neuonc\/nou090","volume":"16","author":"QT Ostrom","year":"2014","unstructured":"Ostrom QT, Chen Y. The descriptive epidemiology of atypical teratoid\/rhabdoid tumors in the United States, 2001\u20132010. Neuro Oncol. 2014;16(10):1392\u20139.","journal-title":"Neuro Oncol"},{"issue":"4","key":"5397_CR16","doi-asserted-by":"publisher","first-page":"629","DOI":"10.21037\/tcr-21-2548","volume":"11","author":"S Xie","year":"2022","unstructured":"Xie S, Yang J, Ma Y, et al. Analysis on diagnosis and treatments of 16 cases of extracranial malignant rhabdoid tumor in children. Transl Cancer Res. 2022;11(4):629\u201338.","journal-title":"Transl Cancer Res"},{"issue":"1","key":"5397_CR17","doi-asserted-by":"publisher","first-page":"e250776","DOI":"10.1136\/bcr-2022-250776","volume":"17","author":"C Douch","year":"2024","unstructured":"Douch C, Merve A, Mankad K, et al. Primary orbital rhabdoid tumour masquerading as atypical persistent foetal vasculature. BMJ Case Rep. 2024;17(1):e250776.","journal-title":"BMJ Case Rep"},{"key":"5397_CR18","doi-asserted-by":"publisher","first-page":"e7","DOI":"10.3928\/01913913-20180215-01","volume":"55","author":"E Ayala Barroso","year":"2018","unstructured":"Ayala Barroso E, Tapia Bahamondes A, Sanchez Espana JC, et al. Primary intraocular malignant rhabdoid tumor without extrascleral compromise. J Pediatr Ophthalmol Strabismus. 2018;55:e7\u20139.","journal-title":"J Pediatr Ophthalmol Strabismus"},{"issue":"1","key":"5397_CR19","doi-asserted-by":"publisher","first-page":"e3","DOI":"10.1016\/j.jcjo.2016.07.023","volume":"52","author":"M Hada","year":"2017","unstructured":"Hada M, Chawla B, Seth R, et al. Primary intraocular malignant rhabdoid tumor presenting as orbital mass with intracranial extension in an adolescent. Can J Ophthalmol. 2017;52(1):e3\u20135.","journal-title":"Can J Ophthalmol"},{"issue":"Online","key":"5397_CR20","first-page":"e18","volume":"50","author":"SJ Shah","year":"2013","unstructured":"Shah SJ, Ali MJ, Mulay K, et al. Primary intraocular malignant extrarenal rhabdoid tumor: a clinicopathological correlation. J Pediatr Ophthalmol Strabismus. 2013;50(Online):e18\u201320.","journal-title":"J Pediatr Ophthalmol Strabismus"},{"issue":"2","key":"5397_CR21","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1111\/his.12460","volume":"66","author":"A Yoshida","year":"2015","unstructured":"Yoshida A, Asano N, Kawai A, et al. Differential SALL4 immunoexpression in malignant rhabdoid tumours and epithelioid sarcomas. Histopathology. 2015;66(2):252\u201361.","journal-title":"Histopathology"},{"issue":"4","key":"5397_CR22","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.3390\/ijms23042053","volume":"23","author":"B Sun","year":"2022","unstructured":"Sun B, Xu L, Bi W, et al. SALL4 oncogenic function in cancers: mechanisms and therapeutic relevance. Int J Mol Sci. 2022;23(4):2053.","journal-title":"Int J Mol Sci"},{"issue":"14","key":"5397_CR23","doi-asserted-by":"publisher","first-page":"22968","DOI":"10.18632\/oncotarget.14952","volume":"8","author":"L Nicole","year":"2017","unstructured":"Nicole L, Sanavia T, Veronese N, et al. Oncofetal gene SALL4 and prognosis in cancer: a systematic review with meta-analysis. Oncotarget. 2017;8(14):22968\u201379.","journal-title":"Oncotarget"},{"issue":"4","key":"5397_CR24","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.molcel.2020.11.046","volume":"81","author":"R Pantier","year":"2021","unstructured":"Pantier R, Chhatbar K, Quante T, et al. SALL4 controls cell fate in response to DNA base composition. Mol Cell. 2021;81(4):845\u201358. e8.","journal-title":"Mol Cell"},{"issue":"3","key":"5397_CR25","doi-asserted-by":"publisher","first-page":"e31490","DOI":"10.1002\/pbc.31490","volume":"72","author":"JI Geller","year":"2025","unstructured":"Geller JI, Renfro LA, Grundy PE, et al. Rhabdoid tumor of the kidney and soft tissues: results from National Wilms Tumor Study-5 and Children\u2019s Oncology Group Study AREN0321. Pediatr Blood Cancer. 2025;72(3):e31490.","journal-title":"Pediatr Blood Cancer"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-026-05397-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-05397-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-05397-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T23:52:32Z","timestamp":1787097152000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-026-05397-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,10]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5397"],"URL":"https:\/\/doi.org\/10.1007\/s12672-026-05397-z","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,10]]},"assertion":[{"value":"18 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and was approved by the institutional review board of the Eye & ENT Hospital of Fudan University (EENT-IRB No.: 2021158). Informed consent to participate was obtained from the patient\u2019s legal guardians.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent to publish was obtained from the patient\u2019s legal guardians.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1206"}}